Weight loss medications like semaglutide and tirzepatide do help people lose weight and belly fat effectively, but a 2026 systematic review of 36 studies found that about 35% of the weight loss comes from muscle rather than fat—higher than the expected 25%. According to Gram Research analysis, this muscle loss exceeded safe benchmarks in two-thirds of medication studies, though lifestyle changes like diet and exercise caused less muscle loss overall. Combining these medications with strength training and adequate protein may help protect muscle during weight loss.
A major review of 36 studies found that popular weight loss medications like semaglutide and tirzepatide do help people shed pounds and dangerous belly fat. However, according to Gram Research analysis, these drugs cause people to lose more muscle than expected—about 35% of their weight loss comes from muscle rather than fat. This is concerning because muscle helps keep your metabolism strong and body functioning well. The review compared these medications to lifestyle changes like diet and exercise, which caused less muscle loss overall. Researchers say we need more studies to understand if this muscle loss causes real health problems.
Key Statistics
A 2026 systematic review of 36 randomized controlled trials found that weight loss medications caused people to lose a median of 34.9% of their weight from muscle, with 68% of studies exceeding the expected 25% benchmark.
In studies using advanced imaging (CT or MRI), all incretin-based medication studies showed muscle loss exceeding the 15% benchmark, compared to lifestyle interventions that preserved muscle better.
Lifestyle interventions in 14 studies produced minimal weight loss (median -2.4%), but when weight loss did occur, muscle loss was less likely to exceed safety benchmarks compared to medication groups.
Among 36 studies examining incretin medications for weight loss, no study measured whether the excess muscle loss caused actual problems with physical function, strength, or mobility.
The Quick Take
- What they studied: How much muscle people lose when taking popular weight loss medications (like Ozempic and Mounjaro) compared to diet and exercise alone
- Who participated: 36 different research studies involving adults with obesity, with an average of 71 people per study. Studies lasted about 6 months on average
- Key finding: Weight loss medications caused people to lose about 35% of their weight from muscle, which is higher than the expected 25%. Diet and exercise caused less muscle loss overall
- What it means for you: If you’re considering these medications, talk to your doctor about combining them with strength training to protect your muscles. The medications definitely work for weight loss, but preserving muscle mass may require extra effort
The Research Details
Researchers searched six major medical databases for all studies published between 2003 and February 2026 that tested weight loss medications (liraglutide, semaglutide, tirzepatide, or dulaglutide) in adults. They only included studies that actually measured how much fat versus muscle people lost, using methods like body scans and imaging. The team found 36 studies that met their strict criteria.
They looked at how much weight people lost overall, how much of that was fat, and how much was muscle. They compared the medications to placebo (fake pills) or lifestyle interventions (diet and exercise). The researchers set benchmarks—expected amounts of muscle loss—based on what normally happens when people lose weight. For most measurement methods, they expected about 25% of weight loss to come from muscle, but for advanced imaging, they expected about 15%.
Because the studies used different methods to measure muscle loss and reported results differently, the researchers couldn’t combine all the data into one big analysis. Instead, they looked at patterns across all the studies to see what was typical.
Understanding body composition—how much of your weight loss is fat versus muscle—is crucial because losing too much muscle can slow your metabolism, weaken your body, and make it harder to keep weight off long-term. This systematic review is important because these medications are prescribed to millions of people, so we need to know if they’re causing unexpected muscle loss that could harm health
About 42% of the studies had low risk of bias, meaning their results are probably reliable. However, only 28% of studies actually planned to measure body composition from the start—most added it as an afterthought. The studies varied widely in how they measured muscle (some used simple scales, others used advanced imaging), which makes comparing results difficult. The median study lasted only 26 weeks, so we don’t know what happens with longer-term use
What the Results Show
The medications consistently produced larger weight loss than placebo or lifestyle changes. People taking incretin medications lost significantly more weight than those in comparison groups. All the medications reduced total body fat and dangerous visceral fat (the kind that surrounds organs).
However, the muscle loss was concerning. Across all the medication studies, the median amount of weight loss that came from muscle was 34.9%—much higher than the expected 25% benchmark. Two-thirds of the medication studies exceeded this benchmark. When researchers looked only at studies using the most reliable measurement methods (CT or MRI imaging), all of them showed muscle loss exceeding the 15% benchmark.
In contrast, lifestyle interventions (diet and exercise) caused much less muscle loss. Half of the lifestyle studies exceeded their respective benchmarks, compared to two-thirds of medication studies. The lifestyle groups lost an average of only 2.4% of their body weight, but when they did lose weight, they preserved muscle better.
Importantly, no study measured whether this extra muscle loss actually caused problems with physical function, strength, or ability to move around. This is a major gap in the research.
All three major medication types (semaglutide, tirzepatide, and liraglutide) showed similar patterns of muscle loss. The amount of muscle loss varied widely between studies—some people lost much more muscle than others, even on the same medication. Visceral fat loss (the dangerous belly fat) was consistently good across all medication groups. The studies that lasted longer didn’t necessarily show different patterns than shorter studies
This is the first comprehensive review to systematically examine muscle loss across all the popular incretin-based medications. Previous research suggested these medications might cause more muscle loss than expected, but this review confirms it’s a widespread pattern across 36 different studies. The finding that lifestyle interventions preserve muscle better aligns with what we know about exercise and weight loss
The biggest limitation is that studies used different methods to measure muscle, making direct comparisons difficult. Most studies were relatively short (median 26 weeks), so we don’t know if muscle loss continues, stabilizes, or reverses with longer use. No study measured whether the extra muscle loss actually caused health problems like weakness or falls. The studies were mostly in people with obesity or type 2 diabetes, so results may not apply to other groups. Publication bias is possible—studies showing concerning results might be less likely to get published
The Bottom Line
If you’re taking or considering these weight loss medications: (1) Combine them with strength training and adequate protein intake to minimize muscle loss (moderate confidence—supported by general exercise science, though not specifically tested in these studies). (2) Have your doctor monitor your physical function and strength, not just weight loss (moderate confidence). (3) Don’t stop taking the medication based on this finding alone—the weight loss and fat loss benefits are real and important (high confidence). (4) Discuss with your doctor whether the muscle loss is a concern for your specific situation (high confidence)
This matters most for people taking these medications long-term, older adults (who are more vulnerable to muscle loss), people with limited mobility, and anyone concerned about maintaining strength. It’s less immediately concerning for younger, active people who can easily add strength training. People considering these medications should discuss muscle preservation strategies with their doctor before starting
Muscle loss likely begins within the first few weeks of taking the medication, as weight loss starts. However, the studies only lasted about 6 months on average, so we don’t know if muscle loss continues indefinitely or plateaus. Benefits from strength training to preserve muscle could appear within 4-8 weeks of consistent training
Frequently Asked Questions
Do weight loss medications like Ozempic cause you to lose muscle?
Yes, research shows these medications cause more muscle loss than expected. A 2026 review found about 35% of weight loss comes from muscle rather than fat. Combining medication with strength training and adequate protein can help minimize this effect.
Is it bad to lose muscle when losing weight?
Losing too much muscle can slow your metabolism, reduce strength, and make weight regain more likely. That’s why experts recommend strength training and adequate protein when taking weight loss medications to preserve muscle mass during weight loss.
How much protein should I eat if I’m taking weight loss medication?
Aim for 0.8 to 1.0 grams of protein per pound of your goal body weight daily. This typically means 25-30g of protein per meal. Combine this with 2-3 strength training sessions weekly to protect muscle while losing weight.
Are weight loss medications still worth taking if they cause muscle loss?
Yes, these medications effectively reduce weight and dangerous belly fat. The muscle loss is a concern but manageable through strength training and proper nutrition. Discuss with your doctor whether the benefits outweigh risks for your specific situation.
How long does it take to lose muscle on weight loss medication?
Muscle loss likely begins within weeks as weight loss starts. Most studies lasted about 6 months, so longer-term effects are unknown. Starting strength training immediately when beginning medication can help minimize muscle loss from the start.
Want to Apply This Research?
- Track weekly strength training sessions (target: 2-3 sessions per week) and daily protein intake in grams (target: 0.8-1.0g per pound of body weight). Monitor these alongside weight loss to ensure you’re preserving muscle
- Add two 30-minute strength training sessions per week focusing on major muscle groups (legs, chest, back, arms). Increase protein at meals—aim for 25-30g per meal. Log these activities in the app to stay accountable
- Monthly: track weight, muscle mass (if available through scale or imaging), and strength metrics (how much you can lift). Quarterly: assess physical function (can you climb stairs easily? How far can you walk?). This helps catch concerning muscle loss early
This article summarizes research findings and should not replace professional medical advice. Weight loss medications can be effective and appropriate for many people, but decisions about taking them should be made with your doctor, who can assess your individual health situation, risk factors, and goals. If you’re taking or considering these medications, discuss muscle preservation strategies, strength training, and protein intake with your healthcare provider or a registered dietitian. This review does not assess whether muscle loss causes actual health problems, so individual outcomes may vary.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.